| Dr Elyse Billow, PHD | |
|
49 Cedar Dr, Great Neck, NY 11021-1935 | |
| (516) 829-6089 | |
| (516) 829-9691 |
| Full Name | Dr Elyse Billow |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 49 Cedar Dr, Great Neck, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053541425 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 9989 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elyse Billow, PHD 49 Cedar Dr, Great Neck, NY 11021-1935 Ph: (516) 829-6089 | Dr Elyse Billow, PHD 49 Cedar Dr, Great Neck, NY 11021-1935 Ph: (516) 829-6089 |
News Archive
TONIX Pharmaceuticals (formerly known as Krele Pharmaceuticals), a specialty central nervous system (CNS) pharmaceutical company, announced results of a new analysis of a Phase 2a study, which previously demonstrated reduced pain, fatigue and tenderness in patients with Fibromyalgia Syndrome (FMS) following bedtime administration of very low dosage (VLD) cyclobenzaprine (CBP).
Patients with stage 2 or stage 3 triple-negative breast cancer (TNBC) who had a pathologic complete response (pCR) after presurgery chemotherapy had increased event-free and overall survival compared with those who had more than minimal residual invasive disease at surgery following presurgery chemotherapy, according to results from the randomized phase II CALGB/Alliance 40603 clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12.
Healthcare Trust of America, Inc., a self-managed, non-traded real estate investment trust, announced the purchase of a medical office portfolio located in Denton, Texas and Lewisville, Texas for approximately $13,500,000.
Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis.
Medivir AB, a research-based pharmaceutical company focused on infectious diseases, announced today that a phase I clinical trial has been initiated with its investigational drug, MIV-711, a cathepsin K inhibitor for the treatment of bone disorders characterized by excessive bone resorption such as osteoporosis, osteoarthritis and bone metastases.
› Verified 4 days ago
Paul M Weinhold, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 45 N Station Plz, Suite 307, Great Neck, NY 11021 Phone: 516-466-8330 Fax: 516-773-6017 | |
Ms. Zina Rutkin, PH.D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 26 Walden Pl, Great Neck, NY 11020 Phone: 718-918-5124 | |
Dr. Daniel J Coletti, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 865 Northern Blvd, Suite 102, Northwell Division Of General Internal Medicine, Great Neck, NY 11021 Phone: 516-622-5035 Fax: 516-622-5005 | |
Dr. Paul R Marcus, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 115 Wooleys Lane, Great Neck, NY 11023 Phone: 516-487-7454 Fax: 516-487-7454 | |
Dr. Isa L. Eliasoph, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 11 Grosvenor Pl, Great Neck, NY 11021 Phone: 516-482-3569 | |
Dr. Gayle Berman, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 29 Barstow Rd Ste 102, Great Neck, NY 11021 Phone: 516-570-2493 Fax: 516-570-2493 |